建立成人肾小球疾病试验核心结局领域的国际德尔菲调查
针对肾小球疾病试验中结局报告不一致的问题,本研究通过两轮国际在线德尔菲调查(英文)建立共识核心结局。1198名参与者完成第一轮(734名患者/照护者,464名医护人员,来自59个国家),700人完成第二轮(412名患者/照护者,288名医护人员)。需透析或移植、肾功能、死亡、心血管疾病、缓解-复发和生活参与被患者/照护者和医护人员评为最重要结局。
要点
- 需透析或移植、肾功能、死亡、心血管疾病、缓解-复发和生活参与是核心重要结局。
- 患者/照护者更重视患者报告结局,医护人员更重视住院、死亡和缓解/复发。
- 建议所有肾小球疾病试验一致报告这些核心结局以改善以患者为中心的决策。
核心结论
- 需透析或移植、肾功能、死亡、心血管疾病、缓解-复发和生活参与是肾小球疾病试验的核心重要结局。
研究设计与样本
- 国际两轮在线德尔菲调查(英文),纳入肾小球疾病患者、照护者和医护人员(≥18岁)。
- 第一轮1198人完成(患者/照护者734人,医护人员464人,来自59个国家)。
- 第二轮700人完成(患者/照护者412人,医护人员288人)。
主要发现
- 需透析或移植、肾功能、死亡、心血管疾病、缓解-复发和生活参与被患者/照护者和医护人员评为最重要结局。
- 患者/照护者比医护人员更重视患者报告结局。
- 医护人员比患者/照护者更重视住院、死亡和缓解/复发。
- 参与者优先考虑的原因归纳为四个主题:面对死亡和复合痛苦、关注肾小球疾病特定目标、保持生活意义、促进自我管理。
临床怎么用
- 在肾小球疾病临床试验中一致报告核心重要结局,以改善以患者为中心的决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Outcomes relevant to treatment decision-making are inconsistently reported in trials involving glomerular disease. Here, we sought to establish a consensus-derived set of critically important outcomes designed to be reported in all future trials by using an online, international two-round Delphi survey in English. To develop this, patients with glomerular disease, caregivers and health professionals aged 18 years and older rated the importance of outcomes using a Likert scale and a Best-Worst scale. The absolute and relative importance was assessed and comments were analyzed thematically. Of 1198 participants who completed Round 1, 734 were patients/caregivers while 464 were health care professionals from 59 countries. Of 700 participants that completed Round 2, 412 were patients/caregivers and 288 were health care professionals. Need for dialysis or transplant, kidney function, death, cardiovascular disease, remission-relapse and life participation were the most important outcomes to patients/caregivers and health professionals. Patients/caregivers rated patient-reported outcomes higher while health care professionals rated hospitalization, death and remission/relapse higher. Four themes explained the reasons for their priorities: confronting death and compounded suffering, focusing on specific targets in glomerular disease, preserving meaning in life, and fostering self-management. Thus, consistent reporting of these critically important outcomes in all trials involving glomerular disease is hoped to improve patient-centered decision-making.
引用
- Carter SA, Logeman C, Howell M, et al. Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease. Kidney Int. 2021. PMID: 33964313. doi:10.1016/j.kint.2021.04.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。